702 related articles for article (PubMed ID: 19714597)
1. The impact of flare on disease costs of patients with systemic lupus erythematosus.
Zhu TY; Tam LS; Lee VW; Lee KK; Li EK
Arthritis Rheum; 2009 Sep; 61(9):1159-67. PubMed ID: 19714597
[TBL] [Abstract][Full Text] [Related]
2. Systemic lupus erythematosus with neuropsychiatric manifestation incurs high disease costs: a cost-of-illness study in Hong Kong.
Zhu TY; Tam LS; Lee VW; Lee KK; Li EK
Rheumatology (Oxford); 2009 May; 48(5):564-8. PubMed ID: 19269959
[TBL] [Abstract][Full Text] [Related]
3. Relationship between flare and health-related quality of life in patients with systemic lupus erythematosus.
Zhu TY; Tam LS; Lee VW; Lee KK; Li EK
J Rheumatol; 2010 Mar; 37(3):568-73. PubMed ID: 20110519
[TBL] [Abstract][Full Text] [Related]
4. Costs associated with severe and nonsevere systemic lupus erythematosus in Canada.
Clarke AE; Urowitz MB; Monga N; Hanly JG
Arthritis Care Res (Hoboken); 2015 Mar; 67(3):431-6. PubMed ID: 25185936
[TBL] [Abstract][Full Text] [Related]
5. Socioeconomic burden of psoriatic arthritis in Hong Kong: direct and indirect costs and the influence of disease pattern.
Zhu TY; Tam LS; Leung YY; Kwok LW; Wong KC; Yu T; Kun EW; Li EK
J Rheumatol; 2010 Jun; 37(6):1214-20. PubMed ID: 20360186
[TBL] [Abstract][Full Text] [Related]
6. The impact of disease activity, treatment and disease severity on short-term costs of systemic lupus erythematosus.
Lacaille D; Clarke AE; Bloch DA; Danoff D; Esdaile JM
J Rheumatol; 1994 Mar; 21(3):448-53. PubMed ID: 8006887
[TBL] [Abstract][Full Text] [Related]
7. Ovarian failure and flares of systemic lupus erythematosus.
Mok CC; Wong RW; Lau CS
Arthritis Rheum; 1999 Jun; 42(6):1274-80. PubMed ID: 10366122
[TBL] [Abstract][Full Text] [Related]
8. Long-term medical costs and resource utilization in systemic lupus erythematosus and lupus nephritis: a five-year analysis of a large medicaid population.
Li T; Carls GS; Panopalis P; Wang S; Gibson TB; Goetzel RZ
Arthritis Rheum; 2009 Jun; 61(6):755-63. PubMed ID: 19479688
[TBL] [Abstract][Full Text] [Related]
9. The effect of menopause on disease activity in systemic lupus erythematosus.
Urowitz MB; Ibañez D; Jerome D; Gladman DD
J Rheumatol; 2006 Nov; 33(11):2192-8. PubMed ID: 16981295
[TBL] [Abstract][Full Text] [Related]
10. Flares in pediatric systemic lupus erythematosus.
Weiss JE; Sison CP; Ilowite NT; Gottlieb BS; Eberhard BA
J Rheumatol; 2007 Jun; 34(6):1341-4. PubMed ID: 17477466
[TBL] [Abstract][Full Text] [Related]
11. Decreasing costs and improving outcomes in systemic lupus erythematosus: using regression trees to develop health policy.
Clarke AE; Bloch DA; Danoff DS; Esdaile JM
J Rheumatol; 1994 Dec; 21(12):2246-53. PubMed ID: 7699625
[TBL] [Abstract][Full Text] [Related]
12. Costs and quality of life of patients with ankylosing spondylitis in Canada.
Kobelt G; Andlin-Sobocki P; Maksymowych WP
J Rheumatol; 2006 Feb; 33(2):289-95. PubMed ID: 16465660
[TBL] [Abstract][Full Text] [Related]
13. Factors associated with active systemic lupus erythematosus after endstage renal disease.
Szeto CC; Li PK; Wong TY; Leung CB; Lui SF
J Rheumatol; 1998 Aug; 25(8):1520-5. PubMed ID: 9712094
[TBL] [Abstract][Full Text] [Related]
14. Societal costs of rheumatoid arthritis in Hong Kong: a prevalence-based cost-of-illness study.
Zhu TY; Tam LS; Li EK
Rheumatology (Oxford); 2011 Jul; 50(7):1293-301. PubMed ID: 21330341
[TBL] [Abstract][Full Text] [Related]
15. Drivers of cost and health-related quality of life in patients with systemic lupus erythematosus (SLE): a Swedish nationwide study based on patient reports.
Bexelius C; Wachtmeister K; Skare P; Jönsson L; Vollenhoven Rv
Lupus; 2013 Jul; 22(8):793-801. PubMed ID: 23761101
[TBL] [Abstract][Full Text] [Related]
16. Direct cost of management and treatment of active systemic lupus erythematosus and its flares in Spain: the LUCIE Study.
Cervera R; Rúa-Figueroa I; Gil-Aguado A; Sabio JM; Pallarés L; Hernández-Pastor LJ; Iglesias M
Rev Clin Esp (Barc); 2013 Apr; 213(3):127-37. PubMed ID: 23398815
[TBL] [Abstract][Full Text] [Related]
17. Direct medical costs and their predictors in patients with rheumatoid arthritis: a three-year study of 7,527 patients.
Michaud K; Messer J; Choi HK; Wolfe F
Arthritis Rheum; 2003 Oct; 48(10):2750-62. PubMed ID: 14558079
[TBL] [Abstract][Full Text] [Related]
18. Costs and quality of life of patients with ankylosing spondylitis in Hong Kong.
Zhu TY; Tam LS; Lee VW; Hwang WW; Li TK; Lee KK; Li EK
Rheumatology (Oxford); 2008 Sep; 47(9):1422-5. PubMed ID: 18635597
[TBL] [Abstract][Full Text] [Related]
19. Climatic influence on the prevalence of noncutaneous disease flare in systemic lupus erythematosus in Hong Kong.
Szeto CC; Mok HY; Chow KM; Lee TC; Leung JY; Li EK; Tsui TK; Yu S; Tam LS
J Rheumatol; 2008 Jun; 35(6):1031-7. PubMed ID: 18398942
[TBL] [Abstract][Full Text] [Related]
20. The cost of care of systemic lupus erythematosus (SLE) in the UK: annual direct costs for adult SLE patients with active autoantibody-positive disease.
Khamashta MA; Bruce IN; Gordon C; Isenberg DA; Ateka-Barrutia O; Gayed M; Donatti C; Guillermin AL; Foo J; Perna A
Lupus; 2014 Mar; 23(3):273-83. PubMed ID: 24356612
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
